SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-036535
Filing Date
2024-02-14
Accepted
2024-02-14 17:02:01
Documents
3
Group Members
LEE S. AINSLIE IIIMAVERICK CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d628447dsc13ga.htm SC 13G/A 69285
2 EX-99.A d628447dex99a.htm EX-99.A 5064
3 EX-99.B d628447dex99b.htm EX-99.B 2947
  Complete submission text file 0001193125-24-036535.txt   79221
Mailing Address 1900 N. PEARL STREET, 20TH FLOOR DALLAS TX 75201
Business Address 1900 N. PEARL STREET, 20TH FLOOR DALLAS TX 75201 214.880.4050
MAVERICK CAPITAL LTD (Filed by) CIK: 0000934639 (see all company filings)

IRS No.: 000000000 | State of Incorp.: TX
Type: SC 13G/A

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Subject) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89180 | Film No.: 24640181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)